Skip to main content

Table 4 CRF identification and management by rheumatologists in RA; PCPs in RA, DM, and the GP

From: Suboptimal cardiovascular risk factor identification and management in patients with rheumatoid arthritis: a cohort analysis

   Group A (RA)
Rh
Group A (RA)
PCP
Group B (DM) Group C (GP) P, Group A (Rh versus PCP) P, all three (PCP) P, A versus C (PCP)
Smoking ID 52 (21%) 167 (67%) 161 (64%) 188 (75%) < 0.0001 0.02 0.0496
  MA 32 (13%) 25 (10%) 28 (11%) 39 (16%) 0.4 0.1 0.08
Weight ID 67 (27%) 111 (44%) 191 (76%) 136 (54%) < 0.0001 < 0.0001 0.03
  MA 15 (6%) 72 (29%) 159 (63%) 99 (39%) < 0.0001 < 0.0001 0.01
BP ID 233 (93%) 243 (97%) 250 (99.6%) 250 (99.6%) 0.07   0.04
  MA 14 (6%) 53 (21%) 169 (67%) 80 (32%) < 0.0001 < 0.0001 0.008
HDL ID 13 (5%) 109 (43%) 190 (76%) 144 (57%) < 0.0001 < 0.0001 0.002
  MA 5 (2%) 34 (14%) 137 (55%) 70 (28%) < 0.0001 < 0.0001 0.0001
LDL ID 14 (6%) 110 (44%) 197(79%) 146 (58%) < 0.0001 < 0.0001 0.004
  MA 4 (2%) 38 (15%) 160 (64%) 78 (31%) < 0.0001 < 0.0001 < 0.0001
TG ID 14 (6%) 109 (43%) 190 (76%) 141 (56%) < 0.0001 < 0.0001 0.006
  MA 5 (2%) 36 (14%) 142 (57%) 70 (28%) < 0.0001 < 0.0001 0.0003
FBG ID 3 (1%) 58 (23%) 237 (94%) 68 (27%) < 0.0001 < 0.0001 0.4
  MA 0 7 (3%) 232 (92%) 19 (8%) 0.02 < 0.0001 0.03
  1. Percentages are calculated as the number of patients with an identified or managed risk factor divided by the total number of patients within the group. BP, blood pressure; CRF, cardiovascular risk factor; DM, diabetes mellitus; FBG, fasting blood glucose; GP, general population; HDL, high-density lipoprotein; ID, identified; LD, low-density lipoprotein; MA, managed; PCP, primary care physician; RA, rheumatoid arthritis; Rh, rheumatologist; TG, triglyceride.